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IN MEMORIAM
Angelika Amon (1967–2020): Breakthrough scientist,
extraordinary mentor, and loyal friend
Rosella Visintin1 and Adele L. Marston2
When asked to write a tribute to our mentor and friend, An-
gelika, 20 years of memorable, funny, and exciting anecdotes
came to mind, some of which we recount below.
Angelika Amon was born in Vienna, Austria on January 10,
1967, and was attracted to science for as long as she could re-
member. Passionate, exuberant, and incorrigibly curious, it is
easy to imagine young Angelika bursting with “why” questions.
Brought up in a family fostering her love for animals and nature,
she aspired to be a zoologist at first, but ended up devoting her
life to discovering the fundamental concepts of biology. In high
school, a black and white movie from the fifties showing chro-
mosomes splitting apart enchanted Angelika and drew her to
molecular biology and genetics. “The way nature works is un-
matched and cells work perfectly,” she used to say with conta-
gious enthusiasm. Determined to pursue her dream, for her
undergraduate thesis she marched—no doubt about that—into
Kim Nasmyth’s office at the Institute of Molecular Pathology in
Vienna. At that time, Kim was new to the city and country, and,
by Angelika’s account, it was her knowledge of the Austrian
waltz and German language that won her a place in his labora-
tory. She remained there for her PhD, graduating in 1993. From
the early days in Kim’s laboratory, Angelika distinguished her-
self as one of the brightest minds of the cell cycle field. Using the
elegant genetics of budding yeast, Angelika made key con-
tributions to our understanding of cell cycle control. She showed
that cyclins are confined within precise cell cycle windows by a
combination of transcriptional and posttranslational regulatory
mechanisms. On the one hand, cyclins self-regulate at the
transcriptional level via sophisticated feedback loops; on the
other, they undergo ubiquitin-mediated degradation to allow
exit from mitosis. She went on to show how this degradation is
turned off to allow entry into the next cell cycle (1).
Following her stellar PhD, and fascinated by the elegant ge-
netics of the fruit fly, Drosophila melanogaster, Angelika landed in
Cambridge, MA, where she began a postdoctoral position in
Ruth Lehmann’s laboratory, marking what was to become a
permanent move to the Massachusetts Institute of Technology
(MIT). However, soon after, Ruth relocated to New York, and,
realizing that Drosophila did not suit her, Angelika chose not to
follow. Instead, in 1996, recognizing her potential, the White-
head Institute appointed Angelika as a Fellow. This launched an
independent career that, from the very beginning, had a major
impact on science and all that were lucky enough to interact
with her. In 1999 she accepted a faculty position in the MIT
Department of Biology and Center for Cancer Research, which
later became the Koch Institute. A Howard Hughes Investigator
since 2000, she was also the Kathleen and Curtis Marble Pro-
fessor in Cancer Research.
Passionate about puzzles and brain teasers, when starting her
laboratory, she returned to yeast, recognizing in this organism
the perfect toy to unravel the mysteries of life. “What’s so in-
credible about yeast is that the rate-limiting step is your brain.
You can do anything you can think of very cleanly and pre-
cisely,” she used to say, and there is no doubt that she fully
exploited this power. Initially, Angelika turned her attention to a
question that had captivated her since graduate school: How is
the cell cycle reset at the end of mitosis? With the field focused
on inactivation of kinase activity, Angelika had the key insight
Angelika Amon, Whitehead Institute, 1997. Photo taken by Susanne Prinz.
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that a phosphatase could be important, leading to the identifi-
cation of the budding yeast Cdc14 phosphatase as a central player
in mitotic exit (2). Together with her first postdoc (R. Visintin),
Angelika next demonstrated that relocation of Cdc14 out of the
nucleolus is under control of a signaling cascade called the mi-
totic exit network (MEN) and is the critical step in mitotic exit.
MEN is a GTPase kinase cascade related to the Hippo pathway
that controls organ size in metazoans and remained an impor-
tant focus of Angelika’s laboratory for the next two decades. She
made numerous fundamental discoveries that provided insight
into how signaling networks operate, including understanding
how spatial cues elicit cellular decisions, how scaffolds facilitate
signaling assemblies, and how signals are translocated across
cellular compartments.
Every five years, Angelikawould start something new. One of
her first new directions was into meiosis, inspired by her final
year at the Institute of Botany in Vienna and friendship with
Franz Klein and Susanne Prinz, who later became her second
postdoc. Angelika’s intuition was to look at meiosis with the eyes
and the tools of a cell cycle scientist (3). Her approaches and
findings brought a breath of fresh air into a field dominated by
homologous recombination studies and accelerated the field
enormously. Frustrated by the lack of sophisticated genetic tools
in yeast for studyingmeiosis compared withmitosis, she devised
a suite of clever approaches and rapidly and generously shared
them with the community, revolutionizing the field. Her sci-
entific accomplishments on meiosis were diverse, ranging from
understanding how cell cycle and chromosome segregation
pathways are rewired, through demonstrating translational
control by an amyloid and revealing the rejuvenating, anti-aging
ability of gametogenesis.
Angelika’s work on mitosis and meiosis revealed potential
reasons for unequal distribution of chromosomes between
daughter cells during cell division. This condition, known as
aneuploidy, is characteristic of cancer cells and is one of the
leading causes of miscarriages and developmental defects when
occurring in germline cells. It was clear that aneuploidy is det-
rimental at organismal levels, but the effect on individual cells
was unknown. This mystery perplexed Angelika such that she
set out to purposefully generate yeast, mouse, and human cells
with defined aneuploidies. In landmark studies, her group found
that, rather than conferring a proliferative advantage, aneu-
ploidy generally decreases fitness (4). In subsequent studies,
they showed that altered gene dosage in aneuploid cells pro-
foundly impacts protein composition. Misfolding of proteins
that lack their binding partners aggregate, which allows for
dosage compensation but also leads to proteotoxic stress.
Therefore, aneuploidy impacts protein quality control pathways
and alters cellular metabolism, resulting in a higher energy re-
quirement. These common properties of aneuploid cells
prompted Angelika to ask whether they could be exploited for
selective elimination. Indeed, her group showed that aneuploid
cells are sensitive to conditions that interfere with protein
translation, folding, and degradation and identified energy and
proteotoxic stress-inducing compounds that selectively inhibit
proliferation of aneuploid cells. Remarkably, signatures of an-
euploid cells may also make them a target for the immune
system. By transplanting aneuploid fetal hematopoietic stem
cells into a wild-type mouse, Angelika’s group found evidence
that aneuploid hematopoietic stem cells were selected against by
the immune system. Collectively, these studies presented a
paradox: If aneuploidy causes a decrease in fitness, why are
cancer cells so frequently aneuploid? Angelika’s group found
that aneuploid yeast cells are prone to genetic instability,
showing increased chromosome loss and impaired DNA damage
repair. Furthermore, the same defined aneuploidies show vari-
ability in cell cycle progression and response to environmental
perturbations, findings that were recapitulated in trisomic mice.
Taken together, these findings indicate that cells encounter se-
lective pressure to adapt for aneuploidy tolerance, increasing
variability and providing the opportunity for advantageous
traits to evolve. Angelika proposed that it is this flexibility of
aneuploid cells that provides the opportunity for rare variants to
emerge, offering a survival advantage that allows the aggressive
proliferation of cancers.
Mitosis, meiosis, and aneuploidy can be considered Angel-
ika’s signature fields of interest, but she nevermissed the chance
to approach a new exciting biological question. Her broad sci-
entific influence is exemplified by the range of fields where she
made a substantial impact. In all of her endeavors, she designed
clean, unambiguous experiments, applying the logical thinking
she had honed as a yeast geneticist to tackle the most complex
problems. She chose systems that were as representative of the
in vivo system as possible, preferring whole organisms over cell
culture. Using organoid culture systems, she demonstrated the
importance of tissue architecture for accurate chromosome
segregation. Her work on cell size showed, using budding yeast,
that DNA content becomes limiting as the amount of cytoplasm
increases, reducing proliferative potential and contributing to
senescence. A recent preprint from her group reports that in-
creased cell size is also detrimental to mouse and human hae-
mopoietic stem cell function and, as in yeast, is associated with
aging (5), another of her key interests. She also worked on mi-
tochondria, where she identified a surveillance mechanism that
monitors protein import to protect mitochondrial function. In all
the fields she chose to study, her work has left a lasting legacy
both through her documented work and the people from her
laboratory and beyond who have been influenced by it.
Angelika’s impressive scientific achievements were recognized
with many awards, including the 2003 National Science Foun-
dation Alan T. Waterman Award, the 2007 Paul Marks Prize for
Cancer Research, the 2008 National Academy of Sciences (NAS)
Award in Molecular Biology, the 2013 Ernst Jung Prize for Medi-
cine, the 2015 Women in Cell Biology Senior Award, and the 2018
Vanderbilt Prize. In 2019, the Carnegie Corporation of New York
included Angelika on their list of Great Immigrants. She won the
2019 Breakthrough Prize in Life Sciences and the 2019 Vilcek Prize
in Biomedical Science. In 2020, she won the Human Frontier
Science Program Nakasone Award and the Ernst W. Bertner
Memorial Award, delivering her acceptance lecture only six days
before her death. She was a member of the NAS (2010) and the
American Academy of Arts and Sciences (2017).
Angelika’s impact on creating an equitable scientific culture
extended beyond her laboratory. She was fair, generous, and
Visintin and Marston Journal of Cell Biology 2 of 3
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committed to making a difference wherever she could. In recent
years, she applied her understanding of the basic cellular biology
of aneuploidy toward the goal of increasing “health, autonomy,
and inclusion of people” with Down syndrome through her co-
directorship of the Alana Down Syndrome Center. She was a
strong advocate of women in science long before it became
fashionable and was not afraid to speak out when she felt
something was not right. She was also a vocal supporter of
fundamental science; her own career is a case in point for how
research on simple budding yeast is critical for informing mo-
lecular processes relevant to disease.
Angelika is world renowned for her razor-sharp mind, ele-
gant experiments, intoxicating laugh, and sense of humor, but
those whowere fortunate enough to be trained by her know that
she was much more than that. First and foremost, she was a
devoted mother and wife: her love for her family was evident in
everything she did. She cared deeply about her students and
colleagues; her generosity and loyalty distinguished her. Many
around her benefited immensely from Angelika’s (often invisi-
ble) support and her encouragement to pursue a scientific career
or to simply “keep going.” She had a remarkable ability to bond
with each individual and nurture diverse personalities. The
environment she created was open and inclusive, making us feel
part of a family, which we like to call the “Amonites.”We shared
so many “lightbulb” moments with Angelika. Rushing into her
office with a new result and watching her come upwith the next
experiment barely before we had connected the dots was elec-
trifying. Both of us were lucky enough to observe her still
working at the bench, which was mesmerizing and incredibly
fun. She would run the craziest time courses to the rhythm of
the Rocky Horror Picture Show or the Rolling Stones, and we
would karaoke and dance. “Persistence is everything” was her
motto and she truly lived up to it.
Group meetings were accompanied by the hiss of the Diet
Coke can (which many attendees of scientific meetings will also
remember) and obligatory apple strudels. Always looking for the
decisive experiment, and impatient during circular discussions,
her mantra was “just do the experiment.” She delivered advice
in a persuasive and direct, but always encouraging, manner. And
persuasive she was for sure; the memory of all the laboratory
members dressed in Elvis costumes for Halloween still brings
laughter. She loved talking about politics, TV series, celebrity
gossip, sports, and books and giving us all (often hilarious) re-
lationship advice. The group camping and ski trips are legend-
ary, and we treasure the memory of wonderful summer and
holiday parties with her family. We remember fondly the be-
spoke goodbye presents collectively made by group members
and even the “surprise” birthday cakes along with (often awk-
ward) group singing. A fierce supporter of all her trainees, the
support, mentorship, and friendship continued after leaving
Angelika’s laboratory. This atmosphere was evident at the 50th
birthday symposium and party, a wonderful reunion of nearly
all laboratory members past and present from around the globe
who did not want to miss the chance to be there.
She truly loved her job and her people. In accepting the
Breakthrough Prize, Angelika said, “Making a discovery is the
best feeling in the world. It’s like Christmas when you were five.
Eureka moments are rare but when they happen, feelings are
priceless. The beauty of experimental science is that these eu-
reka moments are often shared with other scientists, and I’m
privileged to have experienced this.” We believe that this sen-
tence fully captures her passion and generosity. No matter how
well known she became, she preserved her sparkling enthusi-
asm and humbleness.
With great admiration and gratitude for the opportunities
and example that Angelika gave us, we will “keep going.” As we
do, we’ll cherish the picture of her smiling, joyful and enthusi-
astic like a kid in a candy store. We will remember her kissing
her “magical” hands, in celebration of her perfectly executed
experiments, as we continue to be inspired by her. We cannot
but wonder what would have come next in her scientific life.
Archeology? Fossils? Life on other planets? We don’t know, but
we are certain there was no limit to her creativity. We’d like to
think of her somewhere surrounded by the rarest varieties
of orchids, discussing crazy experiments and big theories with
her heroes.
References
1. Amon, A., S. Irniger, and K. Nasmyth. 1994. Closing the cell cycle circle in
yeast: G2 cyclin proteolysis initiated at mitosis persists until the activation
of G1 cyclins in the next cycle. Cell. 77:1037–1050. https://doi.org/10.1016/
0092-8674(94)90443-X
2. Visintin, R., K. Craig, E.S. Hwang, S. Prinz, M. Tyers, and A. Amon. 1998.
The phosphatase Cdc14 triggers mitotic exit by reversal of Cdk-dependent
phosphorylation. Mol. Cell. 2:709–718. https://doi.org/10.1016/S1097
-2765(00)80286-5
3. Lee, B.H., and A. Amon. 2003. Role of Polo-like kinase CDC5 in program-
ming meiosis I chromosome segregation. Science. 300:482–486. https://doi
.org/10.1126/science.1081846
4. Torres, E.M., T. Sokolsky, C.M. Tucker, L.Y. Chan,M. Boselli, M.J. Dunham,
and A. Amon. 2007. Effects of aneuploidy on cellular physiology and cell
division in haploid yeast. Science. 317:916–924. https://doi.org/10.1126/
science.1142210
5. Lengefeld, J., C.-W. Cheng, P. Maretich, M. Blair, H. Hagen, M.R. McRey-
nolds, E. Sullivan, K. Majors, C. Roberts, J.H. Kang, et al. 2020. Cell size is a
determinant of stem cell potential during aging. bioRxiv. https://doi.org/10
.1101/2020.10.27.355388
Visintin and Marston Journal of Cell Biology 3 of 3




 http://rupress.org/jcb/article-pdf/220/2/e202012031/1407192/jcb_202012031.pdf by guest on 05 August 2021
